Latest Insider Transactions at Moderna, Inc. (MRNA)
This section provides a real-time view of insider transactions for Moderna, Inc. (MRNA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Moderna, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Moderna, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 17
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$2,000,000
$200.0 P/Share
|
|
Jun 16
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Jun 16
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,800,000
$200.0 P/Share
|
|
Jun 16
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,000,000
$200.0 P/Share
|
|
Jun 16
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 16
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,000,000
$200.0 P/Share
|
|
Jun 16
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
Jun 14
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,065,000
$213.32 P/Share
|
|
Jun 14
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 14
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-1.23%
|
$4,260,000
$213.32 P/Share
|
|
Jun 14
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.41%
|
$140,000
$7.6 P/Share
|
|
Jun 10
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$2,160,000
$216.7 P/Share
|
|
Jun 09
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Jun 09
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,908,000
$212.3 P/Share
|
|
Jun 09
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,060,000
$212.3 P/Share
|
|
Jun 09
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 09
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,060,000
$212.3 P/Share
|
|
Jun 09
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
Jun 07
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$1,035,000
$207.04 P/Share
|
|
Jun 07
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 03
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$1,880,000
$188.89 P/Share
|
|
Jun 03
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,880,000
$188.89 P/Share
|
|
Jun 03
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Jun 02
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
10,000
-0.62%
|
$1,830,000
$183.9 P/Share
|
|
Jun 02
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+0.61%
|
$0
$0.99 P/Share
|
|
Jun 02
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$915,000
$183.9 P/Share
|
|
Jun 02
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
Jun 02
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
Jun 02
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,647,000
$183.9 P/Share
|
|
Jun 02
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$915,000
$183.9 P/Share
|
|
Jun 02
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
Jun 01
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,062
-55.23%
|
$2,024,346
$183.46 P/Share
|
|
Jun 01
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$920,000
$184.08 P/Share
|
|
Jun 01
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 27
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,148,400
$174.2 P/Share
|
|
May 27
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 27
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
10,000
-0.14%
|
$1,740,000
$174.2 P/Share
|
|
May 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Bona fide gift
|
Direct |
2,000
-0.03%
|
-
|
|
May 26
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
9,000
-0.14%
|
$1,512,000
$168.7 P/Share
|
|
May 26
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$840,000
$168.7 P/Share
|
|
May 26
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$840,000
$168.7 P/Share
|
|
May 26
2021
|
Tal Zvi Zaks Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$125,000
$25.93 P/Share
|
|
May 25
2021
|
Lori M. Henderson General Counsel and Secretary |
SELL
Open market or private sale
|
Direct |
6,600
-87.99%
|
$1,095,600
$166.58 P/Share
|
|
May 25
2021
|
Lori M. Henderson General Counsel and Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
6,600
+46.81%
|
$92,400
$14.85 P/Share
|
|
May 24
2021
|
Stephen Hoge President |
SELL
Open market or private sale
|
Direct |
20,000
-0.25%
|
$3,260,000
$163.89 P/Share
|
|
May 24
2021
|
Stephen Hoge President |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+0.41%
|
$140,000
$7.6 P/Share
|
|
May 24
2021
|
Juan Andres Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$810,000
$162.45 P/Share
|
|
May 24
2021
|
Juan Andres Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$60,000
$12.21 P/Share
|
|
May 21
2021
|
Stephane Bancel Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
11,046
-9.24%
|
$1,822,590
$165.32 P/Share
|